Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

28.04.2025

1 Acta Neuropathol
5 Alzheimers Dement
1 Am J Alzheimers Dis Other Demen
1 Am J Pathol
1 Biochemistry (Mosc)
1 BMC Neurol
2 BMJ
1 Brain
1 Dement Geriatr Cogn Disord
1 Exp Neurol
14 J Alzheimers Dis
1 J Clin Psychiatry
1 J Neuropsychol
1 J Stroke Cerebrovasc Dis
1 Lancet Neurol
1 Nat Med
1 Neurobiol Aging
2 Neurobiol Dis
1 Neurology
3 Neuroscience
1 PLoS Genet
3 PLoS One
1 Proc Natl Acad Sci U S A


    Acta Neuropathol

  1. LANTERO-RODRIGUEZ J, Montoliu-Gaya L, Benedet AL, Vrillon A, et al
    Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.
    Acta Neuropathol. 2025;149:34.
    >> Share


    Alzheimers Dement

  2. KAC PR, Alcolea D, Montoliu-Gaya L, Fernandez S, et al
    Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70172.
    >> Share

  3. BAKER LD, Pa JA, Katula JA, Aslanyan V, et al
    Effects of exercise on cognition and Alzheimer's biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT study.
    Alzheimers Dement. 2025;21:e14586.
    >> Share

  4. SHADYAB AH, Aslanyan V, Jacobs DM, Salmon DP, et al
    Effects of exercise versus usual care on older adults with amnestic mild cognitive impairment: EXERT versus ADNI.
    Alzheimers Dement. 2025;21:e70118.
    >> Share

  5. SALARDINI A, Himali JJ, Abdullah MS, Chaudhari R, et al
    Elevated serum cortisol associated with early-detected increase of brain amyloid deposition in Alzheimer's disease imaging biomarkers among menopausal women: The Framingham Heart Study.
    Alzheimers Dement. 2025;21:e70179.
    >> Share

  6. VALLE-TAMAYO N, Aranha MR, Perez-Gonzalez R, Serrano-Requena S, et al
    Nerve growth factor precursor alterations in neuron-derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum.
    Alzheimers Dement. 2025;21:e70137.
    >> Share


    Am J Alzheimers Dis Other Demen

  7. MOLLALO A, Grekousis G, Florez H, Neelon B, et al
    Alzheimer's Disease Dementia Prevalence in the United States: A County-Level Spatial Machine Learning Analysis.
    Am J Alzheimers Dis Other Demen. 2025;40:15333175251335570.
    >> Share


    Am J Pathol

  8. MAYER MG, Fischer T
    Shared Mechanisms of Blood-Brain Barrier Dysfunction and Neuroinflammation in COVID-19 and Alzheimer's Disease.
    Am J Pathol. 2025 Apr 18:S0002-9440(25)00118.
    >> Share


    Biochemistry (Mosc)

  9. MURALEVA NA, Zhdankina AA, Khlebnikov AI, Kolosova NG, et al
    JNK Signaling Pathway Activity Alterations in the Rat Hippocampus: Effect of Age, Alzheimer's Disease-Like Pathology Development, and the JNK Inhibitor IQ-1S.
    Biochemistry (Mosc). 2025;90:265-275.
    >> Share


    BMC Neurol

  10. JIN T, Huang W, Cheng Y, Cao Z, et al
    Potential association between allergic disease and risk of Alzheimer's disease: insight from genetic analysis.
    BMC Neurol. 2025;25:173.
    >> Share


    BMJ

  11. BAKCHINE S, Colosimo C, Emilsson E, Jonsdottir SE, et al
    Concerns about the approval of lecanemab for Alzheimer's disease.
    BMJ. 2025;389:r778.
    >> Share

  12. IACOBUCCI G
    Lecanemab: Experts criticise European Commission approval of Alzheimer's drug.
    BMJ. 2025;389:r796.
    >> Share


    Brain

  13. ABANTO JT, Dwivedi AK, Imbimbo BP, Espay AJ, et al
    CSF amyloid-beta40 levels are not associated with efficacy outcomes in Alzheimer's disease trials.
    Brain. 2025 Apr 19:awaf143. doi: 10.1093.
    >> Share


    Dement Geriatr Cogn Disord

  14. HONJO Y, Nagai K, Yuri T, Nakai H, et al
    Characteristics of Neuropsychiatric Inventory Questionnaire domain scores related to cognitive function in Alzheimer's Disease Dementia.
    Dement Geriatr Cogn Disord. 2025 Apr 21:1-17. doi: 10.1159/000545759.
    >> Share


    Exp Neurol

  15. KERR NA, Bramlett HM, Sanchez-Molano J, Higueras AF, et al
    Stool-derived extracellular vesicles increase inflammasome signaling and regulate the gut-brain axis after stroke in Alzheimer's disease transgenic mice.
    Exp Neurol. 2025;390:115269.
    >> Share


    J Alzheimers Dis

  16. HE F, Shi WJ, Liu W, Fan JX, et al
    A mass-producible macaque model displays a durable Alzheimer-like cognitive deficit and hallmark amyloid-beta/tau/neurofilament light chain pathologies.
    J Alzheimers Dis. 2025 Apr 23:13872877251334316. doi: 10.1177/13872877251334316.
    >> Share

  17. SINGH-REILLY N, Graff-Radford J, Li D, Mielke MM, et al
    Abeta(42/40) and p-tau 181 as disease biomarkers in atypical Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 23:13872877251333450. doi: 10.1177/13872877251333450.
    >> Share

  18. GHANBARIAN E, Khorsand B, Petersen KK, Nallapu BT, et al
    Cerebrospinal fluid inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrum.
    J Alzheimers Dis. 2025 Apr 22:13872877251335915. doi: 10.1177/13872877251335915.
    >> Share

  19. KSHIRSAGAR S, Deshmukh H, Reddy AP, Reddy AP, et al
    Grounding as a complementary intervention for Alzheimer's disease: Mechanisms, evidence, and potential therapeutic applications.
    J Alzheimers Dis. 2025 Apr 22:13872877251334666. doi: 10.1177/13872877251334666.
    >> Share

  20. CHEN HM, Shen K, Ji L, McGrath C, et al
    Patterns and trends in the burden of Alzheimer's disease and related dementias in China (1990-2021) and predictions to 2040.
    J Alzheimers Dis. 2025 Apr 22:13872877251333108. doi: 10.1177/13872877251333108.
    >> Share

  21. STAMATELOS P, Beratis IN, Hatzaki P, Economou A, et al
    Mild cognitive impairment, Alzheimer's disease dementia, and predictors of driving cessation: A 7-year longitudinal prospective study.
    J Alzheimers Dis. 2025 Apr 22:13872877251333705. doi: 10.1177/13872877251333705.
    >> Share

  22. WANG S, Ni J, Wei M, Li T, et al
    Impact of obesity on neuropsychiatric symptoms in Alzheimer's disease: Insights from the ADNI cohort.
    J Alzheimers Dis. 2025 Apr 22:13872877251331974. doi: 10.1177/13872877251331974.
    >> Share

  23. WEI S, Li C, Li W, Yuan F, et al
    Glial changes and gene expression in Alzheimer's disease from snRNA-Seq and spatial transcriptomics.
    J Alzheimers Dis. 2025 Apr 23:13872877251330320. doi: 10.1177/13872877251330320.
    >> Share

  24. JEONG H, Kim D, Na S, Kim B, et al
    Repeated neuromodulation with low-intensity focused ultrasound in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 23:13872877251333614. doi: 10.1177/13872877251333614.
    >> Share

  25. ZHANG W, Teng F, Lan X, Liu P, et al
    A novel finding relates to the involvement of ATF3/DOCK8 in Alzheimer's disease pathogenesis.
    J Alzheimers Dis. 2025 Apr 23:13872877251336266. doi: 10.1177/13872877251336266.
    >> Share

  26. HEINZE T, Tuchtenhagen M, Knuppel S, Weber D, et al
    EPIC-Potsdam sub-cohort study: The early role of trace elements, oxidative stress, and anthropometrics in Alzheimer's disease and dementia onset.
    J Alzheimers Dis. 2025 Apr 23:13872877251333726. doi: 10.1177/13872877251333726.
    >> Share

  27. JAMAL R, Shaikh MA, Taleuzzaman M, Haque Z, et al
    Key biomarkers in Alzheimer's disease: Insights for diagnosis and treatment strategies.
    J Alzheimers Dis. 2025 Apr 21:13872877251330500. doi: 10.1177/13872877251330500.
    >> Share

  28. MALEK J, Levchenko A, Robinson JO, Fong J, et al
    Dilemmas in diagnosing Alzheimer's disease: The peril and promise of self-fulfilling prophecies.
    J Alzheimers Dis. 2025 Apr 21:13872877251331236. doi: 10.1177/13872877251331236.
    >> Share

  29. KIM H, Kulshreshtha A, Alonso A, Goldstein FC, et al
    The association between pulse wave velocity and cerebrospinal fluid biomarkers for Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 21:13872877251331235. doi: 10.1177/13872877251331235.
    >> Share


    J Clin Psychiatry

  30. PRICE MZ, Small GW
    Benefits and Risks of New Tests for Alzheimer's Disease.
    J Clin Psychiatry. 2025;86:25com15837.
    >> Share


    J Neuropsychol

  31. BRUNO D, Reilly J
    Editorial introduction to the special issue on biomarker-based diagnosis of Alzheimer's disease: A synthesis of the commentaries.
    J Neuropsychol. 2025 Apr 23. doi: 10.1111/jnp.12427.
    >> Share


    J Stroke Cerebrovasc Dis

  32. KE J, Li J, Yu M
    Letter to the editor regarding "Exploring the bidirectional relationships between alzheimer's disease and cerebral small vessel disease: Insights from mendelian randomization".
    J Stroke Cerebrovasc Dis. 2025 Apr 20:108326.
    >> Share


    Lancet Neurol

  33. MATAR E, Halliday GM
    Biological effects of pathologies in Lewy body diseases: why timing matters.
    Lancet Neurol. 2025;24:441-455.
    >> Share


    Nat Med


  34. Microglia drive amyloid-beta clearance in immunized patients with Alzheimer's disease.
    Nat Med. 2025 Apr 22. doi: 10.1038/s41591-025-03677.
    >> Share


    Neurobiol Aging

  35. PAITEL ER, Pettigrew C, Moghekar A, Miller MI, et al
    Alzheimer's disease cerebrospinal fluid biomarker levels and APOE genetic status are associated with hippocampal-cerebellar functional connectivity.
    Neurobiol Aging. 2025;151:107-116.
    >> Share


    Neurobiol Dis

  36. MORAIS RF, Sousa JM, Koba C, Andres L, et al
    Differential involvement of neurotransmitter pathways in AD, bvFTD and MCI: Whole-brain MRI analysis.
    Neurobiol Dis. 2025;209:106897.
    >> Share

  37. VAN KRUINING D, Losen M, Dehairs J, Swinnen JV, et al
    Early plasma ceramide and sphingomyelin levels reflect APOE genotype but not familial Alzheimer's disease gene mutations in female 5xFAD mice, with brain-region specific sphingolipid alterations.
    Neurobiol Dis. 2025 Apr 17:106923. doi: 10.1016/j.nbd.2025.106923.
    >> Share


    Neurology

  38. LEE JY, Han K, Kim J, Lim JS, et al
    Association Between Metabolic Syndrome and Young-Onset Dementia: A Nationwide Population-Based Study.
    Neurology. 2025;104:e213599.
    >> Share


    Neuroscience

  39. MORAIS RF, Pires R, Jesus T, Lemos R, et al
    Cognitive impairment in neurodegenerative diseases: A trans-diagnostic approach using a lesion-symptom mapping analysis.
    Neuroscience. 2025;573:214-227.
    >> Share

  40. GALAL A, Moustafa A, Salama M
    Transforming neurodegenerative disorder care with machine learning: Strategies and applications.
    Neuroscience. 2025;573:272-285.
    >> Share

  41. JOLIVALT CG, Calcutt NA, Masliah E
    Corrigendum to "Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease" [Neuroscience 202 (2012) 405-412].
    Neuroscience. 2025;575:94.
    >> Share


    PLoS Genet

  42. ASKAROVA A, Yaa RM, Marzi SJ, Nott A, et al
    Genetic risk for neurodegenerative conditions is linked to disease-specific microglial pathways.
    PLoS Genet. 2025;21:e1011407.
    >> Share


    PLoS One

  43. LICHTY JD, Mane H, Yarmey VR, Miguel AS, et al
    Amyloid beta induces hormetic-like effects through major stress pathways in a C. elegans model of Alzheimer's Disease.
    PLoS One. 2025;20:e0315810.
    >> Share

  44. KAMIYA M, Osawa A, Otaka E, Kato K, et al
    Exploring emotion recognition in patients with mild cognitive impairment and Alzheimer's dementia undergoing a rehabilitation program emotion recognition in patients with dementia.
    PLoS One. 2025;20:e0322213.
    >> Share

  45. JOHNSON KJ, Johnson K, Grant A, Taglialatela G, et al
    Photobiomodulation therapy increases neural stem cell pool in aged 3xTg-AD mice.
    PLoS One. 2025;20:e0321668.
    >> Share


    Proc Natl Acad Sci U S A

  46. PAULSON AL, Zhang L, Prichard AM, Singer AC, et al
    40 Hz sensory stimulation enhances CA3-CA1 coordination and prospective coding during navigation in a mouse model of Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2025;122:e2419364122.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016